companydata.dkcompanydata.dk

CEPHALON FINLAND A/S: Financial statements 2022

CVR: 29245037

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

CEPHALON FINLAND A/S (CVR 29245037) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 6,993,435 and a net result of DKK 2,153,940 compared with DKK 1,333,536 the year before. That is an increase of 21.2% compared with the year before. Equity in the 2022 report amounted to DKK 6,866,373. The solvency ratio was 66.9%. The company had 5 employees in the financial year.

Gross Profit
DKK 6,993,435
Profit/Loss
DKK 2,153,940
Equity
DKK 6,866,373
Total Assets
DKK 10,260,808
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-7M2.2M6.9M5
2021-5.8M1.3M6M6
2020-4.4M973K5.6M5
2019-3.8M720K5.3M3
2018-3.2M267K4.8M3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CEPHALON FINLAND A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

CEPHALON FINLAND A/S: The 2021 annual report is outMay 4, 2022

CEPHALON FINLAND A/S has published its annual report for 2021. Gross profit came to DKK 5,772,257, and the net result was DKK 1,333,536.

CEPHALON FINLAND A/S appoints new auditorMay 3, 2022

As of May 3, 2022, RéVision+ Statsautoriseret Revisionsanpartsselskab has been appointed auditor of CEPHALON FINLAND A/S.

Auditor steps down at CEPHALON FINLAND A/SMay 3, 2022

As of May 3, 2022, RéVision+ Ejendomme ApS has stepped down as auditor of CEPHALON FINLAND A/S.

About CEPHALON FINLAND A/S

CEPHALON FINLAND A/S is a Danish company of the type Aktieselskab based in Nørresundby, founded in 2006. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rolf Nejsum. The board consists of Bjørn Helmer Johnsen (chair), Rolf Nejsum and Vesa Antero Toropainen. The company is owned by Scanmed AS Norway. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK 7,078,554 and a net result of DKK 2,059,375 compared with DKK 296,806 the year before. Equity in the 2025 report amounted to DKK 7,193,391.

Source: annual report 2025, Danish Business Authority